| Literature DB >> 30833413 |
Sjors G J G In 't Veld1, Thomas Wurdinger1.
Abstract
Liquid biopsies have been considered the holy grail in achieving effective cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies. Currently, blood-based liquid biopsy measurements focus on the evaluation of biomarker types, including circulating tumor DNA, circulating tumor cells, extracellular vesicles (exosomes and oncosomes), and tumor-educated platelets (TEPs). Despite the potential of individual techniques, each has its own advantages and disadvantages. Here, we provide further insight into TEPs.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30833413 DOI: 10.1182/blood-2018-12-852830
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113